MA26507A1 - Compositions pharmaceutiques d'aerosol - Google Patents

Compositions pharmaceutiques d'aerosol

Info

Publication number: MA26507A1
Authority: MA; Morocco
Prior art keywords: pharmaceutical compositions; aerosol pharmaceutical; aerosol; compositions; pharmaceutical
Prior art date: 1997-06-13

Application number

MA25113A

Other languages

English (en)

Inventor

David Lewis

Brian Meakin

Paolo Ventura

Gaetano Brambilla

Raffaella Garzia

On Davis Ganderton

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-13

Filing date

1998-06-12

Publication date

2004-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA26507(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-06-12 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2004-12-20 Publication of MA26507A1 publication Critical patent/MA26507A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MA25113A 1997-06-13 1998-06-12 Compositions pharmaceutiques d'aerosol MA26507A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9712434A GB2326334A (en)	1997-06-13	1997-06-13	Pharmaceutical aerosol compositions

Publications (1)

Publication Number	Publication Date
MA26507A1 true MA26507A1 (fr)	2004-12-20

Family

ID=10814179

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25113A MA26507A1 (fr)	1997-06-13	1998-06-12	Compositions pharmaceutiques d'aerosol

Country Status (45)

Country	Link
EP (2)	EP1219293A3 (fr)
JP (1)	JP4380802B2 (fr)
KR (1)	KR100546239B1 (fr)
CN (1)	CN1138532C (fr)
AR (1)	AR012977A1 (fr)
AT (1)	ATE222751T1 (fr)
AU (1)	AU729966B2 (fr)
BG (1)	BG63906B1 (fr)
BR (1)	BR9805993B1 (fr)
CA (1)	CA2263445C (fr)
CO (1)	CO4940408A1 (fr)
CZ (1)	CZ295521B6 (fr)
DE (1)	DE69807420T3 (fr)
DK (1)	DK0920302T4 (fr)
DZ (1)	DZ2516A1 (fr)
EA (1)	EA001259B1 (fr)
EE (1)	EE03664B1 (fr)
ES (1)	ES2182351T5 (fr)
GB (1)	GB2326334A (fr)
GE (1)	GEP20012462B (fr)
HK (1)	HK1022271A1 (fr)
HR (1)	HRP980317B1 (fr)
HU (1)	HU228487B1 (fr)
ID (1)	ID21491A (fr)
IL (1)	IL128484A (fr)
IN (1)	IN189317B (fr)
IS (1)	IS2435B (fr)
IT (1)	IT1293803B1 (fr)
MA (1)	MA26507A1 (fr)
ME (2)	MEP44008A (fr)
MY (1)	MY119074A (fr)
NO (1)	NO327775B1 (fr)
NZ (1)	NZ334149A (fr)
PL (1)	PL193721B1 (fr)
PT (1)	PT920302E (fr)
RS (1)	RS51274B (fr)
SA (1)	SA98190821B1 (fr)
SI (1)	SI0920302T2 (fr)
SK (1)	SK284430B6 (fr)
TN (1)	TNSN98087A1 (fr)
TR (1)	TR199900288T1 (fr)
TW (1)	TW555570B (fr)
UA (1)	UA70289C2 (fr)
WO (1)	WO1998056349A1 (fr)
ZA (1)	ZA985136B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9616237D0 (en)	1996-08-01	1996-09-11	Norton Healthcare Ltd	Aerosol formulations
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
IT1303788B1 (it) *	1998-11-25	2001-02-23	Chiesi Farma Spa	Formulazioni di aerosol medicinali.
DZ2947A1 (fr)	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
IT1313553B1 (it)	1999-07-23	2002-09-09	Chiesi Farma Spa	Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317904B1 (it)	1999-09-11	2003-07-15	Glaxo Group Ltd	Formulazione farmaceutica di propionato di fluticasone.
EP1523976A3 (fr) *	1999-11-23	2005-06-22	Glaxo Group Limited	Formulations pharmaceutiques de salméterol
US20030032632A1 (en) *	1999-12-24	2003-02-13	Crispps Leslie Alan	Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) *	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) *	2000-05-12	2003-08-27	Chiesi Farma Spa	Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
UA73986C2 (uk) *	2000-05-22	2005-10-17	К'Єзі Фармачеутічі С.П.А.	АЕРОЗОЛЬНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ <font face="Symbol">b</font>2-АДРЕНЕРГІЧНИЙ АГОНІСТ ТРИВАЛОЇ ДІЇ, ДОЗУЮЧИЙ ІНГАЛЯТОР ПІД ТИСКОМ ТА СПОСІБ ЙОГО ЗАПОВНЕННЯ
WO2002072067A2 (fr) *	2001-03-12	2002-09-19	Glaxo Group Limited	Formulation aerosol pharmaceutique
ES2222294T3 (es)	2001-07-02	2005-02-01	Chiesi Farmaceutici S.P.A.	Formulacion optimizada de tobramicina para administracion en forma de aerosol.
EP1340492A1 (fr) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Formulations d'aérosol pour l'administration par voie pulmonaire de medicaments avec effet systémique
EP1340503A1 (fr) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Formule d'une solution pour aerosol contenant des dérivés d'esters de 3,17 estratrien pour administration pulmonale
WO2003074024A1 (fr)	2002-03-01	2003-09-12	Chiesi Farmaceutici S.P.A	Preparation superfine de formoterol
DE10214263A1 (de) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
DE60216242T2 (de) *	2002-06-06	2007-05-24	Chiesi Farmaceutici S.P.A.	Lösung von Wirkstoffen in HFA-Treibgasen mittels Emulsionen
JP2006516545A (ja) *	2003-02-04	2006-07-06	クリサリステクノロジーズインコーポレイテッド	パーフルオロカーボン及びハイドロフルオロカーボン製剤及びその製法及び使用法
CA2519523C (fr)	2003-03-20	2012-03-13	Boehringer Ingelheim Pharmaceuticals, Inc.	Formulation pour un aerosol-doseur utilisant des hydro-fluoro-alcanes comme propulseurs
EP1915985A1 (fr)	2003-03-20	2008-04-30	Boehringer Ingelheim Pharmaceuticals Inc.	Formulation pour une dose mesurée utilisant des hydro-fluoro-alcanes en tant que propulseurs
EP1595531A1 (fr)	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression
EP1809243B2 (fr)	2004-07-02	2022-06-08	Boehringer Ingelheim International GmbH	Formulations de suspensions aerosol contenant tg 227 ea en tant qu'agent propulseur
DE102006017320A1 (de)	2006-04-11	2007-10-18	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en)	2006-10-31	2006-12-13	Univ London Pharmacy	Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en)	2007-06-27	2007-08-08	Generics Uk Ltd	Pharmaceutical compositions
BRPI0819259A2 (pt) *	2007-11-07	2019-10-01	Astrazeneca Ab	formulações de pó seco compreendendo derivados do ácido ascórbico.
CN105854136A (zh) *	2010-09-06	2016-08-17	奇斯药制品公司	计量剂量吸入器和使用该计量剂量吸入器的方法
JP5409594B2 (ja) *	2010-12-22	2014-02-05	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	加圧式定量吸入器のための安定な製薬学的溶液製剤
EP2819669B1 (fr)	2012-02-28	2021-04-21	Boehringer Ingelheim International GmbH	Nouvelle formulation de tiotropium contenant un gaz propulseur
RU2504402C1 (ru) *	2012-11-20	2014-01-20	Шолекс Девелопмент Гмбх	Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en)	2014-02-13	2014-04-02	Cardiff Scintigraphics Ltd	Pressurised metered dose inhalers and method of manufacture
WO2016018892A1 (fr)	2014-07-29	2016-02-04	3M Innovative Properties Company	Procédé de préparation d'une composition pharmaceutique
WO2017167737A1 (fr)	2016-03-31	2017-10-05	Chiesi Farmaceutici S.P.A.	Dispositif d'inhalation d'aérosol
PH12019500577B1 (en) *	2016-09-19	2023-09-08	Mexichem Fluor Sa De Cv	Pharmaceutical composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3775960D1 (de) †	1986-03-10	1992-02-27	Burghart Kurt	Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
EP0259383B1 (fr) †	1986-03-10	1991-01-23	Kurt Dr. Burghart	Produit pharmaceutique et son procede de preparation
US4899874A (en) †	1988-04-26	1990-02-13	Rehrig-Pacific Company, Inc.	Stackable low depth bottle case
GB8828477D0 (en) *	1988-12-06	1989-01-05	Riker Laboratories Inc	Medical aerosol formulations
US5225183A (en) †	1988-12-06	1993-07-06	Riker Laboratories, Inc.	Medicinal aerosol formulations
DE3905726A1 (de) *	1989-02-24	1990-08-30	Hoechst Ag	Druckgaspackung und treibmittel fuer aerosole
CA2094266C (fr) †	1990-10-18	1999-06-01	Robert K. Schultz	Formulations
GB9024365D0 (en) *	1990-11-09	1991-01-02	Glaxo Group Ltd	Medicaments
EP0504112A3 (en) *	1991-03-14	1993-04-21	Ciba-Geigy Ag	Pharmaceutical aerosol formulations
DE69231991T2 (de) †	1991-06-10	2002-04-04	Schering Corp., Kenilworth	Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
DE69208660T2 (de) †	1991-06-10	1996-07-11	Schering Corp., Kenilworth, N.J.	Fluorchlorkohlenwasserstoffreie aerosolformulierungen
DE4123668A1 (de) *	1991-07-17	1993-01-21	Rovema Gmbh	Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) *	1991-07-17	1993-01-21	Schwabe Willmar Gmbh & Co	Aerosol-zubereitung und verwendung eines treibmittels dafuer
WO1993011745A1 (fr) *	1991-12-12	1993-06-24	Glaxo Group Limited	Medicaments
ATE150296T1 (de) *	1991-12-18	1997-04-15	Minnesota Mining & Mfg	Aerosolzusammensetzungen für arzneimittelsuspensionen
SK280911B6 (sk) *	1992-12-09	2000-09-12	Boehringer Ingelheim Pharmaceuticals, Inc.	Farmaceutický prostriedok
US5502076A (en) *	1994-03-08	1996-03-26	Hoffmann-La Roche Inc.	Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) *	1994-04-11	1996-04-16	The Center For Innovative Technology	Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) †	1994-05-02	1996-07-09	Henry; Richard A.	Lidocaine-vasoconstrictor aerosol preparation
EP0759744B1 (fr) †	1994-05-13	2001-10-17	Aradigm Corporation	Formulation en aerosol contenant un narcotique
US5653961A (en) †	1995-03-31	1997-08-05	Minnesota Mining And Manufacturing Company	Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) †	1995-06-07	1997-06-03	Abbott Laboratories	Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) †	1995-09-04	1995-11-08	Bioglan Lab Ltd	Compositions and device for their administration
AU3453897A (en) *	1996-07-08	1998-02-02	Rhone-Poulenc Rorer Limited	Medicinal cyclosporin-a aerosol solution formulation
KR20000069275A (ko) †	1996-12-04	2000-11-25	새들러 테리 아이언	약학 조성물과 그 투여를 위한 장치
US6461591B1 (en) †	1997-02-05	2002-10-08	Jago Research Ag	Medical aerosol formulations

1997
- 1997-06-13 GB GB9712434A patent/GB2326334A/en not_active Withdrawn
- 1997-07-28 IT IT97MI001798A patent/IT1293803B1/it active IP Right Grant
1998
- 1998-06-10 AT AT98937474T patent/ATE222751T1/de active
- 1998-06-10 RS YUP-69/99A patent/RS51274B/sr unknown
- 1998-06-10 KR KR1019997001274A patent/KR100546239B1/ko not_active IP Right Cessation
- 1998-06-10 GE GEAP19984709A patent/GEP20012462B/en unknown
- 1998-06-10 EA EA199900201A patent/EA001259B1/ru not_active IP Right Cessation
- 1998-06-10 SI SI9830245T patent/SI0920302T2/sl unknown
- 1998-06-10 PL PL98331531A patent/PL193721B1/pl unknown
- 1998-06-10 ME MEP-440/08A patent/MEP44008A/xx unknown
- 1998-06-10 JP JP50162299A patent/JP4380802B2/ja not_active Expired - Lifetime
- 1998-06-10 EE EEP199900055A patent/EE03664B1/xx unknown
- 1998-06-10 ID IDW990051A patent/ID21491A/id unknown
- 1998-06-10 ME MEP-2008-440A patent/ME00333B/me unknown
- 1998-06-10 CA CA002263445A patent/CA2263445C/fr not_active Expired - Lifetime
- 1998-06-10 PT PT98937474T patent/PT920302E/pt unknown
- 1998-06-10 AU AU86262/98A patent/AU729966B2/en not_active Expired
- 1998-06-10 CN CNB988008300A patent/CN1138532C/zh not_active Expired - Lifetime
- 1998-06-10 DE DE69807420T patent/DE69807420T3/de not_active Expired - Lifetime
- 1998-06-10 EP EP02007496A patent/EP1219293A3/fr not_active Withdrawn
- 1998-06-10 DK DK98937474T patent/DK0920302T4/da active
- 1998-06-10 ES ES98937474T patent/ES2182351T5/es not_active Expired - Lifetime
- 1998-06-10 WO PCT/EP1998/003533 patent/WO1998056349A1/fr active IP Right Grant
- 1998-06-10 SK SK176-99A patent/SK284430B6/sk not_active IP Right Cessation
- 1998-06-10 TR TR1999/00288T patent/TR199900288T1/xx unknown
- 1998-06-10 HU HU0001339A patent/HU228487B1/hu unknown
- 1998-06-10 NZ NZ334149A patent/NZ334149A/xx not_active IP Right Cessation
- 1998-06-10 IL IL12848498A patent/IL128484A/en not_active IP Right Cessation
- 1998-06-10 CZ CZ1999462A patent/CZ295521B6/cs not_active IP Right Cessation
- 1998-06-10 EP EP98937474A patent/EP0920302B2/fr not_active Expired - Lifetime
- 1998-06-10 BR BRPI9805993-9A patent/BR9805993B1/pt active IP Right Grant
- 1998-06-12 ZA ZA985136A patent/ZA985136B/xx unknown
- 1998-06-12 HR HR980317A patent/HRP980317B1/xx not_active IP Right Cessation
- 1998-06-12 CO CO98033837A patent/CO4940408A1/es unknown
- 1998-06-12 AR ARP980102805A patent/AR012977A1/es not_active Application Discontinuation
- 1998-06-12 MY MYPI98002641A patent/MY119074A/en unknown
- 1998-06-12 MA MA25113A patent/MA26507A1/fr unknown
- 1998-06-12 TN TNTNSN98087A patent/TNSN98087A1/fr unknown
- 1998-06-13 DZ DZ980126A patent/DZ2516A1/fr active
- 1998-06-18 IN IN1604DE1998 patent/IN189317B/en unknown
- 1998-07-08 TW TW087111036A patent/TW555570B/zh not_active IP Right Cessation
- 1998-10-06 UA UA99020906A patent/UA70289C2/uk unknown
- 1998-11-25 SA SA98190821A patent/SA98190821B1/ar unknown
1999
- 1999-02-09 NO NO19990594A patent/NO327775B1/no not_active IP Right Cessation
- 1999-02-11 IS IS4974A patent/IS2435B/is unknown
- 1999-03-01 BG BG103221A patent/BG63906B1/bg unknown
2000
- 2000-02-28 HK HK00101210A patent/HK1022271A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUP0001339A3 (en)	2000-10-30
BG63906B1 (bg)	2003-06-30
ES2182351T3 (es)	2003-03-01
AR012977A1 (es)	2000-11-22
CA2263445C (fr)	2008-09-09
CZ46299A3 (cs)	1999-07-14
HUP0001339A2 (hu)	2000-09-28
IN189317B (fr)	2003-02-08
NO990594L (no)	1999-04-13
AU729966B2 (en)	2001-02-15
EP1219293A2 (fr)	2002-07-03
EA001259B1 (ru)	2000-12-25
DZ2516A1 (fr)	2004-11-08
SK17699A3 (en)	1999-07-12
IL128484A (en)	2004-09-27
GB9712434D0 (en)	1997-08-13
GEP20012462B (en)	2001-06-25
GB2326334A (en)	1998-12-23
WO1998056349A1 (fr)	1998-12-17
PL331531A1 (en)	1999-07-19
KR20000068171A (ko)	2000-11-25
AU8626298A (en)	1998-12-30
HK1022271A1 (en)	2000-08-04
DE69807420D1 (de)	2002-10-02
PT920302E (pt)	2002-11-29
YU6999A (sh)	2000-03-21
TNSN98087A1 (fr)	2005-03-15
UA70289C2 (uk)	2004-10-15
MEP44008A (en)	2011-02-10
SK284430B6 (sk)	2005-04-01
ID21491A (id)	1999-06-17
ES2182351T5 (es)	2007-03-16
KR100546239B1 (ko)	2006-01-26
EP0920302B2 (fr)	2006-06-21
EP0920302A1 (fr)	1999-06-09
HRP980317B1 (en)	2002-06-30
HU228487B1 (en)	2013-03-28
DE69807420T3 (de)	2006-11-16
RS51274B (sr)	2010-12-31
IT1293803B1 (it)	1999-03-10
NZ334149A (en)	2000-07-28
CZ295521B6 (cs)	2005-08-17
EP0920302B1 (fr)	2002-08-28
NO327775B1 (no)	2009-09-21
JP2000516965A (ja)	2000-12-19
ZA985136B (en)	1999-01-07
MY119074A (en)	2005-03-31
TW555570B (en)	2003-10-01
CA2263445A1 (fr)	1998-12-17
TR199900288T1 (xx)	1999-09-21
BR9805993B1 (pt)	2009-05-05
DE69807420T2 (de)	2003-05-08
ME00333B (me)	2011-02-10
IS2435B (is)	2008-10-15
EP1219293A3 (fr)	2003-05-28
CN1138532C (zh)	2004-02-18
JP4380802B2 (ja)	2009-12-09
EE03664B1 (et)	2002-04-15
SI0920302T2 (sl)	2006-10-31
SA98190821B1 (ar)	2006-11-19
ATE222751T1 (de)	2002-09-15
BR9805993A (pt)	1999-08-31
DK0920302T4 (da)	2006-10-09
IL128484A0 (en)	2000-01-31
ITMI971798A1 (it)	1999-01-28
NO990594D0 (no)	1999-02-09
BG103221A (en)	1999-09-30
SI0920302T1 (en)	2002-12-31
DK0920302T3 (da)	2002-12-23
EE9900055A (et)	1999-08-16
CO4940408A1 (es)	2000-07-24
PL193721B1 (pl)	2007-03-30
HRP980317A2 (en)	1999-04-30
EA199900201A1 (ru)	1999-06-24
IS4974A (is)	1999-02-11
CN1229355A (zh)	1999-09-22

Publication	Publication Date	Title
MA26507A1 (fr)	2004-12-20	Compositions pharmaceutiques d'aerosol
DE69530325D1 (de)	2003-05-15	Aerosol-arzneiformulierungen
IS4706A (is)	1998-03-31	Lyfjasamsetningar
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
BR9610153A (pt)	1999-01-05	Formulações farmacêuticas
DK1073417T3 (da)	2003-03-24	Farmaceutisk aerosolformulering
MA26553A1 (fr)	2004-12-20	Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
ID18352A (id)	1998-04-02	Komposisi-komposisi farmasi
DE69822172D1 (de)	2004-04-08	Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
IS2515B (is)	2009-06-15	Lyfjasamsetningar
ITMI941169A0 (it)	1994-06-06	Formulazioni farmaceutiche
MA26531A1 (fr)	2004-12-20	Composition pharmaceutique
EE200000330A (et)	2001-08-15	Farmatseutilised kompositsioonid
PT941100E (pt)	2003-10-31	Composicoes farmaceuticas
ITMI942166A0 (it)	1994-10-21	Composizioni farmaceutiche miorilassanti
FI973280A (fi)	1997-08-08	Farmaseuttinen koostumus
FI962738A (fi)	1996-07-03	Farmaseuttiset koostumukset
BR9605777A (pt)	1998-08-25	Composição farmacêutica
NO994436L (no)	1999-09-13	Farmasöytiske sammensetninger
BR9605131A (pt)	1998-07-07	Composição farmacêutica
DK1037604T3 (da)	2005-04-11	Farmaceutiske aerosolsammensætninger
HUP0004274A3 (en)	2002-03-28	Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof
BR1100755A (pt)	2006-05-09	composição farmacêutica
BR1101151A (pt)	2003-08-12	Compostos e composição farmacêutica
ITMI972373A1 (it)	1999-04-23	Composizioni farmaceutiche ad attivita'analgesica